Merus BV diskutieren
Merus BV
Symbol: MRUS / Name: Merus / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
-
-
Gesundheit | Biotechnologie | Niederlande
hat $
(Laufzeit überschritten)
Merus will yield meaningful clinical data in the near future.
A lucrative partnership was signed with Incyte last year for which they received $120 million upfront and a common share purchase of $80 million. Incyte in return received exclusive rights for up to 11 bispecific antibody research programs utilizing Merus' Biclonics technology, which included two preclinical immuno-oncology candidates.
The technology of Merus has the potential to be sufficiently differentiated from monoclonal antibodies due to improved tumor cell killing activity and lower toxicity.
(Laufzeit überschritten)
Neueste Beiträge
Wolf_of_WS in Travere Therapeutics Inc. diskutieren